{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:50:05Z","timestamp":1791406205135,"version":"4.3.3"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urolonc.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:17:38Z","timestamp":1790853458000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sociodemographic barriers to receiving adjuvant systemic therapy after nephrectomy for renal cell carcinoma"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5715-9965","authenticated-orcid":false,"given":"Maximilian","family":"Filzmayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Petix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Quarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Carmignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Micali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"He\u00df-Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Humke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix K.-H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.09.002_bib0001","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/2192568217696696","article-title":"Effect of social support and marital status on perceived surgical effectiveness and 30-day hospital readmission","volume":"7","author":"Adogwa","year":"2017","journal-title":"Global Spine J"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0002","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","article-title":"Structural racism and health inequities in the USA: evidence and interventions","volume":"389","author":"Bailey","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0003","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.socscimed.2014.03.022","article-title":"Incorporating intersectionality theory into population health research methodology: challenges and the potential to advance health equity","volume":"110","author":"Bauer","year":"2014","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2024.102156","article-title":"The impact of demographics and socioeconomic status on the receipt of immunotherapy for stage III melanoma","volume":"57","author":"Coogan","year":"2024","journal-title":"Surg Oncol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001314","article-title":"Racial disparities in nephrectomy and mortality among patients with renal cell carcinoma: findings from SEER","volume":"3","author":"Ikuemonisan","year":"2023","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2022.06.022","article-title":"Other-cause mortality and access to care in metastatic renal cell carcinoma according to race\/ethnicity","volume":"40","author":"Sorce","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0007","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1007\/s11255-026-05141-0","article-title":"Racial\/ethnic differences in time to nephrectomy and its association with cancer-specific mortality in localized renal cell carcinoma","volume":"58","author":"Filzmayer","year":"2026","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0008","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1002\/cncr.30146","article-title":"Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era","volume":"122","author":"Rose","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.19535","article-title":"Association between Food and Drug Administration approval and disparities in immunotherapy use among patients with cancer in the US","volume":"5","author":"Ermer","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0010","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1056\/NEJMoa1611406","article-title":"Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy","volume":"375","author":"Ravaud","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0011","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2017.09.008","article-title":"Adjuvant sunitinib for high-risk renal cell carcinoma after nephrectomy: subgroup analyses and updated overall survival results","volume":"73","author":"Motzer","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0012","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa2106391","article-title":"Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma","volume":"385","author":"Choueiri","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0013","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa2312695","article-title":"Overall survival with adjuvant pembrolizumab in renal-cell carcinoma","volume":"390","author":"Choueiri","year":"2024","journal-title":"New Engl J Med"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0014","unstructured":"NCCN clinical practice guidelines in oncology (NCCN guidelines): kidney cancer 2018, Version 4. National Comprehensive Cancer Network (NCCN), Plymouth Meeting, United States."},{"key":"10.1016\/j.urolonc.2026.09.002_bib0015","unstructured":"EAU guidelines: Edition presented at the EAU Annual Congress in Amsterdam 2022. European Association of Urology (EAU), Arnhem, the Netherlands."},{"key":"10.1016\/j.urolonc.2026.09.002_bib0016","unstructured":"National Comprehensive Cancer Network (NCCN). Plymouth Meeting, United States. Version 3."},{"key":"10.1016\/j.urolonc.2026.09.002_bib0017","unstructured":"EAU guidelines: Edition presented at the EAU Annual Congress in London 2026. European Association of Urology (EAU), Arnhem, the Netherlands."},{"key":"10.1016\/j.urolonc.2026.09.002_bib0018","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JU.0000000000001912","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2019.11.010","article-title":"A plea for optimizing selection in current adjuvant immunotherapy trials for high-risk nonmetastatic renal cell carcinoma according to expected cancer-specific mortality","volume":"18","author":"Palumbo","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0020","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.18632\/oncotarget.24675","article-title":"High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis","volume":"9","author":"Chandrasekar","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0021","doi-asserted-by":"crossref","first-page":"604.e601","DOI":"10.1016\/j.urolonc.2020.02.028","article-title":"Survival outcomes and practice trends for off-label use of adjuvant targeted therapy in high-risk locoregional renal cell carcinoma","volume":"38","author":"Chakiryan","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.12813","article-title":"Demographic factors associated with Non-guideline\u2013Based treatment of kidney cancer in the United States","volume":"4","author":"Howard","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0023","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov), National cancer institute, DCCPS, surveillance research program, 2025."},{"key":"10.1016\/j.urolonc.2026.09.002_bib0024","unstructured":"National Cancer Institute. Age and cancer risk. https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/age."},{"key":"10.1016\/j.urolonc.2026.09.002_bib0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12957-026-04511-3","article-title":"Prognostic impact of adjacent organ invasion on cancer-specific mortality in non-metastatic renal cell carcinoma","volume":"24","author":"Filzmayer","year":"2026","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2026.111924","article-title":"Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based study","volume":"52","author":"Filzmayer","year":"2026","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0027","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00345-025-05992-9","article-title":"Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study","volume":"43","author":"de Angelis","year":"2025","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0028","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/bju.16780","article-title":"Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study","volume":"136","author":"Longoni","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0029","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eururo.2006.02.034","article-title":"Tumor size improves the accuracy of TNM predictions in patients with renal cancer","volume":"50","author":"Karakiewicz","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0030","doi-asserted-by":"crossref","first-page":"46.e41","DOI":"10.1016\/j.urolonc.2013.06.010","article-title":"A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma","volume":"32","author":"Bianchi","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0031","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/pros.70130","article-title":"Effect of marital status on years of life lost from metastatic prostate cancer according to race\/ethnicity","volume":"86","author":"Quarta","year":"2026","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0032","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1200\/JCO.2013.49.6489","article-title":"Marital status and survival in patients with cancer","volume":"31","author":"Aizer","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0033","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/pon.5890","article-title":"Intersectionality in cancer care: a systematic review of current research and future directions","volume":"31","author":"Kelly-Brown","year":"2022","journal-title":"Psychooncology"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0034","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00000478-200404000-00002","article-title":"Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome","volume":"28","author":"Cheville","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","article-title":"Prognostic significance of morphologic parameters in renal cell carcinoma","volume":"6","author":"Fuhrman","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2026.09.002_bib0036","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMp0904131","article-title":"A strategy for health care reform\u2013toward a value-based system","volume":"361","author":"Porter","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926007301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926007301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:53:45Z","timestamp":1791402825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926007301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":36,"alternative-id":["S1078143926007301"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.09.002","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sociodemographic barriers to receiving adjuvant systemic therapy after nephrectomy for renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}